You are here

CAR-T

China dominates CAR-T therapies

China dominates CAR-T therapies

Clinical Trials Arena

Flag link:

ASCO: BMS pitches Breyanzi as the first CAR-T for CLL. But will a single-arm trial persuade the FDA?

ASCO: BMS pitches Breyanzi as the first CAR-T for CLL. But will a single-arm trial persuade the FDA?

Fierce Pharma

Bristol Myers Squibb

clinical trials

Flag link:

J&J Makes $245M Play to Develop Next-Gen CAR-T Therapies

J&J Makes $245M Play to Develop Next-Gen CAR-T Therapies

BioSpace

Cellular Biomedicine

diffuse large B-cell lymphoma

Flag link:

J&J, Legend's Carvykti cut risk of progression or death by whopping 74% in earlier myeloma, leaked abstract shows

J&J, Legend's Carvykti cut risk of progression or death by whopping 74% in earlier myeloma, leaked abstract shows

Fierce Pharma

Bristol Myers Squibb

Multiple Myeloma

Flag link:

Caribou gets FDA fast track for allogeneic CAR-T

Caribou gets FDA fast track for allogeneic CAR-T

Biopharma Reporter

Caribou Biosciences

Multiple Myeloma

Flag link:

Gilead’s Yescarta extends survival in lymphoma study

Gilead’s Yescarta extends survival in lymphoma study

BioPharma Dive

Gilead Sciences

large B-cell lymphoma

Flag link:

Johnson & Johnson shelves Carvykti's UK launch amid manufacturing shortfalls

Johnson & Johnson shelves Carvykti's UK launch amid manufacturing shortfalls

Fierce Pharma

Flag link:

Cancer drug startup Cargo raises $200M to solve CAR-T relapse

Cancer drug startup Cargo raises $200M to solve CAR-T relapse

BioPharma Dive

Cargo Therapeutics

Flag link:

OCI-led CAR-T leukemia therapy receives €2.5m from EIC

OCI-led CAR-T leukemia therapy receives €2.5m from EIC

Pharmaphorum

Flag link:

Bristol Myers details landmark Abecma multiple myeloma data that ASH turned down

Bristol Myers details landmark Abecma multiple myeloma data that ASH turned down

Fierce Pharma

Bristol Myers Squibb

Multiple Myeloma

Flag link:

Bristol Myers claims win with CAR-T therapy Breyanzi in leukemia

Bristol Myers claims win with CAR-T therapy Breyanzi in leukemia

Endpoints

Bristol Myers Squibb

Flag link:

After years of back-and-forth, Gilead's CAR-T Yescarta sways England's cost watchdog NICE

After years of back-and-forth, Gilead's CAR-T Yescarta sways England's cost watchdog NICE

Fierce Pharma

Gilead Sciences

Flag link:

Kite swoops in to buy Carl June-founded Tmunity, gaining key to Penn's CAR-T research apparatus

Kite swoops in to buy Carl June-founded Tmunity, gaining key to Penn's CAR-T research apparatus

Fierce Biotech

Gilead Sciences

Flag link:

ASH: Novartis stays the course with cell therapy bet as competitors line up 'off-the-shelf' options

ASH: Novartis stays the course with cell therapy bet as competitors line up 'off-the-shelf' options

Fierce Biotech

Flag link:

ASH: In next BCMA myeloma race, Gracell dazzles with 100% response rate as Pfizer, BMS place their bets

ASH: In next BCMA myeloma race, Gracell dazzles with 100% response rate as Pfizer, BMS place their bets

Fierce Biotech

Multiple Myeloma

Bristol Myers Squibb

Flag link:

ASH: Bristol Myers bolsters Breyanzi's case in earlier lymphoma amid clash with Gilead

ASH: Bristol Myers bolsters Breyanzi's case in earlier lymphoma amid clash with Gilead

Fierce Pharma

Bristol Myers Squibb

B-cell lymphoma

Flag link:

With Neogene buy and a CAR-T in the clinic, AstraZeneca builds up cell therapy 'library'

With Neogene buy and a CAR-T in the clinic, AstraZeneca builds up cell therapy 'library'

Fierce Biotech

Neogene Therapeutics

Flag link:

Beam jumps back into off-the-shelf CAR-T race after FDA lifts clinical hold

Beam jumps back into off-the-shelf CAR-T race after FDA lifts clinical hold

Fierce Biotech

Beam Therapeutics

clinical trials

Flag link:

Sana lays off 15%, trims pipeline to keep funding flowing to off-the-shelf CAR-Ts

Sana lays off 15%, trims pipeline to keep funding flowing to off-the-shelf CAR-Ts

Fierce Biotech

Sana Biotechnology

Flag link:

Pulling back the curtain on AstraZeneca’s CAR-T work

Pulling back the curtain on AstraZeneca’s CAR-T work

EP Vantage

Flag link:

Pages